Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
Teen scientist finds solution to tackle water quality issues

Teen scientist finds solution to tackle water quality issues

For some of us it was an exciting time of creative experimentation. For others it was a time of botched and badly displayed data. For 16-year-old Maria Elena Grimmett, it's a blast. And she isn't peddling baking soda and vinegar volcanoes. Grimmett is tackling serious water quality issues that threaten the health of rivers, streams and groundwater. When she was just 14 years old, Grimmett was the youngest person published in the Journal of Environmental Quality. [More]
IU scientists find evidence that invisible war between microorganisms may affect human health

IU scientists find evidence that invisible war between microorganisms may affect human health

Health experts have warned for years that the overuse of antibiotics is creating "superbugs" able to resist drugs treating infection. [More]
Discovery could put individuals with relapsing UTIs on fast track for new therapeutic regimen

Discovery could put individuals with relapsing UTIs on fast track for new therapeutic regimen

It's one thing to grow bacteria in a test tube, perform a screen in the lab, and find a mutation in the pathogen's genes. It's a whole other thing, and much rarer, to find the exact same mutation in nature--in this case, in E. coli in urine samples from some 500 patients suffering from relapsing urinary tract infections. [More]
Hospitals can make patients sick, reveals Consumer Reports

Hospitals can make patients sick, reveals Consumer Reports

Hospitals are thought to be sterile, safe environments where sick people get better, not sicker. But that's not always the case according to a new investigation by Consumer Reports into hospital-acquired infections. [More]
Europe has increasing prevalence of fungal resistance, warns ESCMID

Europe has increasing prevalence of fungal resistance, warns ESCMID

The European Society of Clinical Microbiology and Infectious Disease – an organization that explores the risks and best practices in infectious disease – is imploring global healthcare professionals and bodies to take a more active role in the growing problem of fungal resistance. [More]
Wayne State leads landmark study that examines clinical use of polymyxin B to treat superbugs

Wayne State leads landmark study that examines clinical use of polymyxin B to treat superbugs

With the decline of the development of new antibiotics due to the complexity and expense of discovering them, there has been a rapid growth of antibiotic resistant pathogens that is one of the leading causes of death. With the help of a nearly $4.9 million, 5-year grant from the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, Wayne State University School of Medicine researchers are leading a landmark multi-center, international study that will provide essential information to clinicians for use of polymoxin B in critically ill patients where no other treatments will work. [More]
Landmark study to provide critical information for optimized use of polymyxin B in critically ill patients

Landmark study to provide critical information for optimized use of polymyxin B in critically ill patients

With the decline of the development of new antibiotics due to the complexity and expense of discovering them, there has been a rapid growth of antibiotic resistant pathogens that is one of the leading causes of death. [More]
Study finds strong link between diabetes and TB in tropical Australia

Study finds strong link between diabetes and TB in tropical Australia

A 20-year study by James Cook University scientists has found a strong link between diabetes and tuberculosis in tropical Australia. [More]
Antimicrobial coating for portable communication devices developed by Lucideon and King’s

Antimicrobial coating for portable communication devices developed by Lucideon and King’s

International materials technology specialist Lucideon has developed a new infection control method to tackle problems associated with digital technology in hospitals. [More]
Mix of bacteria living in guts may band together to ward off dangerous infections

Mix of bacteria living in guts may band together to ward off dangerous infections

Like a collection of ragtag villagers fighting off an invading army, the mix of bacteria that live in our guts may band together to keep dangerous infections from taking hold, new research suggests. [More]
MSU scientists suggest that common glaucoma medication could be used to treat TB

MSU scientists suggest that common glaucoma medication could be used to treat TB

A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind. [More]
Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Chicken, turkey and pork sold in grocery stores harbors disease-causing bacteria known as Klebsiella pneumoniae, according to a new study. The research, which was published online today in the journal Clinical Infectious Diseases, shows that contaminated meat may be an important source of human exposure to Klebsiella. [More]
Use of dicloxacillin linked to INR decrease in patients taking vitamin K antagonists

Use of dicloxacillin linked to INR decrease in patients taking vitamin K antagonists

Researchers have found an association between treatment with the antibiotic dicloxacillin and a decrease in international normalized ratio (INR; a measure of blood coagulation) levels among patients taking the vitamin K antagonists warfarin or phenprocoumon, according to a study in the July 21 issue of JAMA. [More]
Synthetic sugar could be latest weapon against superbugs

Synthetic sugar could be latest weapon against superbugs

A special type of synthetic sugar could be the latest weapon in the fight against superbugs. A team of scientists from The University of Queensland and Queensland biotechnology company Alchemia have discovered a potential new class of antibiotics inspired by sugar molecules produced by bacteria. [More]
MGB Biopharma begins MGB-BP-3 Phase I clinical trial for treatment of Clostridium difficile infections

MGB Biopharma begins MGB-BP-3 Phase I clinical trial for treatment of Clostridium difficile infections

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections. [More]
Study: 10% of health care providers prescribe antibiotics for patients with cold, bronchitis or other ARI

Study: 10% of health care providers prescribe antibiotics for patients with cold, bronchitis or other ARI

10 percent of health care providers write an antibiotic prescription for nearly every patient (95 percent or more) who walks in with a cold, bronchitis or other acute respiratory infection (ARI), according to a new Centers for Disease Control and Prevention-supported study published in the Annals of Internal Medicine and led by the Veterans Affairs Salt Lake City Health Care System and the University of Utah. [More]
New approach holds great promise for developing effective treatments for human mitochondrial diseases

New approach holds great promise for developing effective treatments for human mitochondrial diseases

Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases. [More]
Antibiotics may increase risk of juvenile arthritis

Antibiotics may increase risk of juvenile arthritis

Taking antibiotics may increase the risk that a child will develop juvenile arthritis, according to a study from Rutgers University, University of Pennsylvania and Nemours A.I. duPont Hospital for Children published today in Pediatrics. [More]
NDSU assistant professor receives NIH grant to study regulation of transporters in Gram-negative bacteria

NDSU assistant professor receives NIH grant to study regulation of transporters in Gram-negative bacteria

Christopher Colbert, assistant professor of biochemistry at North Dakota State University, Fargo, has received a $348,000 grant award from the National Institute of General Medical Sciences of the National Institutes of Health to conduct research on structure-function relationships of iron transport and transcriptional regulation in Gram-negative bacteria. [More]
Nitric oxide released through nanotechnology may be a new way to treat, prevent acne

Nitric oxide released through nanotechnology may be a new way to treat, prevent acne

GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology. [More]
Advertisement
Advertisement